Browsing by Subject "Qatar"

Now showing 1 - 4 of 4
  • Thumbnail Image
    Item
    Country Report 2018: Qatar
    (2018) Farouky, Naila; Khatib, Haneen
    The Qatari Law of Associations and Private Institutions does not permit the operation of non-registered groups. The law is clear that philanthropic organizations must be registered and monitored by the Ministry of Civil Service and Housing Affairs, and the Ministry has the right to dissolve an organization. While individuals are free to submit a registration application to the above mentioned ministry, some of the requirements for founding members of organizations are not very clear, including Chapter One, Article 2, Section 2 (D) of the law, "Founding or joining member shall: have good conduct and reputation." There is no available explanation on what defines “good reputation and conduct."
  • Thumbnail Image
    Item
    Infection risks associated with the 2022 FIFA World Cup in Qatar
    (Elsevier, 2022-11-22) Al-Tawfiq, Jaffar A.; Gautret, Philippe; Schlagenhauf, Patricia; Medicine, School of Medicine
  • Thumbnail Image
    Item
    MERS-CoV recently re-emerged in Qatar, Saudi Arabia, its feasible global health risks amid FIFA world cup 2022 and salient counteracting strategies – an update
    (Wolters Kluwer, 2023-02-01) Chopra, Hitesh; Islam, Md Aminul; Chandran, Deepak; Emran, Talha B.; El-Shall, Nahed A.; Al-Tawfiq, Jaffar A.; Dhama, Kuldeep; Medicine, School of Medicine
  • Thumbnail Image
    Item
    Seroprevalence of West Nile Virus among Healthy Blood Donors from Different National Populations Residing in Qatar
    (Elsevier, 2021) Dargham, Soha R.; Al-Sadeq, Duaa W.; Yassine, Hadi M.; Ahmed, Muna; Kunhipurayil, Hasna; Humphrey, John M.; Abu-Raddad, Laith J.; Nasrallah, Gheyath K.; Medicine, School of Medicine
    Objective: To estimate the age- and nationality-specific West Nile virus (WNV) seroprevalence in select Middle East and North Africa (MENA) populations residing in Qatar. Methods: Sera were collected from male blood donors attending Hamad Medical Corporation. A total of 1,948 sera were tested for anti-WNV antibodies using Serion ELISA classic IgG and IgM kits. Results: Overall, seroprevalence estimates of WNV-specific IgG and IgM antibodies were 10.4% and 3.3%, respectively. Country-specific WNV-specific IgG seroprevalence was estimated to be 37.0% (34/92) in Sudanese, 33.0% in Egyptians (66/200), 13.0% (26/200) in Indians, 10.6% (11/104) in Iranians, 10.2% (14/137) in Yemenis, 9.2% (18/195) in Pakistanis, 7.0% (14/199) in Jordanians, 5.4% (6/111) in Filipinos, 2.5% (5/200) in Palestinians, 2.5% (5/200) in Syrians, 1.5% (3/200) in Qataris, and 0.9% (1/110) in Lebanese. Seroprevalence of WNV-specific IgM was lowest in Iranians (0/77), Lebanese (0/108), and Filipinos (0/107) at 0.0%, and was highest in Sudanese at 10.0% (8/80). While there seemed to be apparent trends in the prevalence of WNV-IgM and WNV-IgG antibodies, none of these trends were found to be statistically significant. Conclusion: The findings support the circulation of WNV in human populations in different countries of the MENA region. Seroprevalence was highest in Sudanese and Egyptians and lowest in Qataris and nationals of the Levant. The findings call for further animal, vector, and human studies, such as studying the actual prevalence of the viral RNA in blood donors to assess the risk of viral transmission through blood donation and for a better characterization of the epidemiology of this infection in this part of the world.